Posts Tagged ‘Ultrasound’

Page 1 of 3123

Fairview Southdale Hospital in Edina installs Toshiba’s 16-channel Titan 1.5T system

Fairview Southdale Hospital in Edina installs Toshiba’s 16-channel Titan 1.5T system

Fairview Southdale Hospital in Edina, Minn., improved its advanced imaging capabilities and patient comfort by installing the first 16-channel Vantage TitanTM 1.5T scalable system from Toshiba America Medical Systems, Inc. Fairview will use the system for all general MR exams, as well as breast and cardiac imaging, and expand its capabilities by offering prostate imaging to patients.

“Toshiba’s 16-channel Titan 1.5T will enable us to offer more services to our patients and explore new ways of imaging,” said Judy Sager, director, Radiology, Fairview Health Services. “For instance, we plan to utilize the system to visualize CSF bulk flow without contrast to improve diagnoses of CSF disorders non-invasively.”

The 16-channel Titan 1.5T offers patient-friendly features, including a 71 cm bore and feet first exams to reduce claustrophobia. Toshiba’s exclusive Pianissimo™ noise-reduction technology, advanced non-contrast imaging, integrated coils and intuitive M-Power user interface make the system easier to use for the clinician and more comfortable for the patient.

“The 1.5T MR series offers hospitals like Fairview the option to invest in a scalable MR system that meets their clinical needs today, with the opportunity to easily upgrade as their needs change in the future,” said Stuart Clarkson, director, MR Business Unit, Toshiba. “Titan 1.5T improves comfort and compliance, resulting in faster exams and improved patient satisfaction.”

Fairview also utilizes a Toshiba AquilionTM ONE dynamic volume CT and an earlier version of the Vantage Titan 1.5T MR.

Source : http://www.news-medical.net/news/20121203/Fairview-Southdale-Hospital-in-Edina-installs-Toshibas-16-channel-Titan-15T-system.aspx

Full story

Research report on global ophthalmic instrumentation industry

Research report on global ophthalmic instrumentation industry

Reportlinker.com announces that a new market research report is available in its catalogue: Global Ophthalmic Instrumentation Industry

This report analyzes the worldwide markets for Ophthalmic Instrumentation in Thousands of Units and US$ Million by the following Product Segments: Diagnostic Devices (Perimeters, Refractors, Slit Lamps, Tonometers, Fundus Cameras, Lens Meters, Ophthalmoscopes, Diagnostic Ultrasound Equipment, Corneal Topography Systems, & Diagnostic Imaging Systems), and Surgical Products (Ophthalmic Disposables, Ophthalmic Lasers, & Ophthalmic Surgical Microscope). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, The Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. A six-year historic analysis is also provided for these markets. The report profiles 128 companies including many key and niche players such as Abbott Medical Optics, Inc., Alcon, Inc., Bausch & Lomb, Inc., Carl Zeiss Meditec AG, Ellex Medical Lasers Limited, Iridex Corp., Lumenis Ltd., Nidek Co. Ltd., Topcon Corporation, and Topcon Medical Systems, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONSStudy Reliability and Reporting Limitations I-1Disclaimers I-2Data Interpretation & Reporting Level I-2Quantitative Techniques & Analytics I-3Product Definitions and Scope of Study I-3Diagnostic Devices I-4Perimeters I-4Refractors I-4Slit Lamps I-4Tonometers I-4Fundus Cameras I-4Ophthalmoscopes I-4Diagnostic Ultrasound Equipment I-4Corneal Topography Systems I-5Diagnostic Imaging Systems I-5Surgical Products I-5Ophthalmic Lasers I-5Ophthalmic Surgical Microscopes I-5Ophthalmic Disposables I-5II. EXECUTIVE SUMMARY

1. GLOBAL MARKET OVERVIEW AND ANALYSIS II-1

Eyeing the Ophthalmic Potential II-1

Factors Underpinning Demand for Ophthalmic Instrumentation II-2

Ophthalmic Fact File II-2

Where the Growth Lies II-2

Demographics Spell Opportunities II-3

Table 1: Worldwide Distribution of Population by Country/

Region: 2011 (includes corresponding Graph/Chart) II-3

Table 2: Worldwide Distribution of 65+ Population by

Region/Country: 2011 (includes corresponding Graph/Chart) II-4

Table 3: Percentage Share of Global Population by Age Group,Worldwide: 2025 (includes corresponding Graph/Chart) II-4Market Dynamics II-4Cataract Surgical Market: Providing Lucrative Opportunities II-4A Statistical Review II-5Table 4: World Market for Cataract Procedures (2004-2010)(in Million) (includes corresponding Graph/Chart) II-5

Table 5: Global Cataract Market by Region (2011) -

Percentage Shares of Procedures for United States, Europe,

Asia Pacific, and Rest of the World (includes corresponding

Graph/Chart) II-5

Table 6: Cataract Market Worldwide by Product Segment (2011) -Percentage Share Breakdown of Revenues for IntraocularLenses (IOLs), Viscoelastics, Equipment, Instruments andOthers (includes corresponding Graph/Chart) II-6Table 7: Distribution of Ophthalmic Devices by TreatmentModality (includes corresponding Graph/Chart) II-6Diagnostics Ride the Sophistication Wave II-6Fundus Cameras II-6Evolving Technologies in Corneal Topography II-7Viewing Beyond the Conventional Visual Boundaries II-7Latest Surgical Tools to Propel Ophthalmic Equipment Sector II-8Integration of Ophthalmology and Material Science II-9Competition II-9Table 8: Leading Players in the Global Ophthalmic DiagnosticInstrument Market (2012): Percentage Share Breakdown ofRevenues for Topcon Corp., Carl Zeiss AG, and Others(includes corresponding Graph/Chart) II-9Worldwide Ophthalmic Diagnostic Market: Market Presence ofSelect Market Participants II-10

2. PRODUCT OVERVIEW II-11

Introduction II-11

Ophthalmology and Instrumentation II-11

Human Eye Analysis – A Valuable Health Indicator II-11

Types of Ophthalmic Instruments II-11

A. Ophthalmic Diagnostic Systems II-12

Ophthalmic Diagnostics Goes High Tech II-12

The Constituents II-12

Procedures for Measuring Eye Defects II-12

Perimeters II-13

Refractometer II-13

Slit Lamps II-13

Tonometers II-13

Fundus Cameras and Fundus Reflectometers II-14

Ocular Fundus Reflectometry II-14

Types of Ocular Fundus Reflectometry II-15

Lens Meters II-15

Ophthalmoscopes II-16

Ultrasound Equipment II-16

Corneal Topography Systems II-16

Use of Corneal Topography in Data Measurement and

Presentation II-16

Method of Studying Topographic Displays II-16

Use of Topography in Refractive Surgery II-17

B. Ophthalmic Surgical Products II-18

Ophthalmic Disposables II-18

Ophthalmic Lasers II-18

Role of Lasers in Medical and Ophthalmic Fields II-18

Origin and Development of Laser Surgery Techniques II-19

Types of Lasers II-19

Therapeutic Ophthalmic Lasers II-20

Argon Laser II-21

Q-switched Nd-YAG Laser II-21

Krypton Laser II-22

CO2 Laser II-22

Diode Laser II-22

Erbium Lasers II-22

Excimer Laser II-22

Excimer Lasers Available in the Market II-23

Frequency-Doubled, Tripled, Quadrupled Lasers II-23

Laser Sources for Surgical Effect II-24

Laser-Tissue Interactions II-24

Laser Photodisruption II-24

Laser Photocoagulation II-24

Role of Iris Color II-25

Disadvantages of Using Laser Scalpel II-25

Laser Phaco II-26

Ophthalmic Surgical Microscopes II-26

Other Ophthalmic Devices II-26

Keratometers II-26

Phaco Splitter II-27

Scalpel II-27

Ophthalmodynamometer II-27

Ophthalmodiaphanoscope II-27

3. OPHTHALMIC SURGERY MARKET – TECHNOLOGIES AND TRENDS II-28Table 9: Global Ophthalmic Surgery Market Breakdown by SurgeryProcedure (includes correspondingGraph/Chart) II-28A. Cataract Surgery II-28B. Refractive Surgery II-28Types of Refractive Surgery Procedures II-29Laser Vision Correction – A Broader Insight II-29Photorefractive Keratectomy (PRK) II-30Bottlenecks in PRK Procedure II-31Radial Keratotomy (RK) II-31Laser in-situ Keratomileusis (LASIK) II-32LASIK Vs. PRK II-32Custom LASIK – A New Milestone II-32Advantages of Custom LASIK technology II-33Wavefront: A Revolutionary Technology for Irregular Astigmatism II-33Manufacturers Offering Wavefront Technology II-34Femtosecond Laser – A New Innovation II-34Other Alternative Refractive Procedures II-34LASEK (Laser Epithelial Keratomileusis) II-34PAI (Photoablative Inlay) II-35Phototherapeutic Keratectomy (PTK) II-35Intrastromal Corneal Ring (Intacs) II-35Phakic Intraocular Lenses II-35

4. AN INSIGHT INTO EYES & EYE DISEASES II-36

Human Eyes – The Most Precious Possession II-36

Anatomy of Human Eye II-36

Process of Vision II-36

Effect of Sun Rays II-36

A Review of Various Eye Diseases II-37

A. Corneal Diseases II-37

Table 10: Leading Causes of Blindness Worldwide (includes

corresponding Graph/Chart) II-37

Macular Degeneration II-37

Cataract II-38

Types of Cataracts and their Common Causes II-38

Cataract Removal Techniques II-38

Phacoemulsification II-39

Glaucoma II-39

Surgical Treatment of Glaucoma II-39

Angiogenesis II-39

Astigmatism II-40

Presbyopia II-40

B. Ocular Defects Related to Nutritional Disorders II-40

Xerophthalmia, Caused by Vitamin A Deficiency II-40

Deficiency of Thiamine Leads to Amblyopia II-40

Retinal Anemia and Optic Atrophy Due to Vitamin B-12

Deficiency II-40

Vitamin C Deficiency Leads to Eye Related Hemorrhages II-40

C. Common Eye Related Problems Among Diabetics II-40

Blurred Vision II-41

Cataract in Diabetics (Differing from Normal Cataract) II-41

Macular Edema II-41

Mucormycosis II-41

Diplopia II-41

Gout II-42

Wilson’s Disease II-42

Hyperlipoproteinemias II-42

Ocular Albinism II-42

Keratoconus II-43

5. PRODUCT INTRODUCTIONS/INNOVATIONS II-44Carl Zeiss Meditec Introduces FORUM® 3.0 Data Management System II-44NIDEK Introduces CV-9000 II-44Bausch & Lomb and TPV Launch VICTUS™ Femtosecond LaserPlatform in the EU II-44Bausch & Lomb Launches enVista™ II-45Ellex to Introduce Integre Pro™ II-45Ellex to Introduce Diagnostic Ultrasound Mode for Eye Cubed™ II-45Lumenis Introduces Vision One™ II-45Topcon to Unveil New Range of Products II-46Ellex Introduces Integre Yellow™ Laser Photocoagulator II-46Keeler Introduces Applanation Tonometer II-47Bausch & Lomb to Launch Crystalens® AO Lens II-47Bausch + Lomb Storz® Ophthalmic Instruments Unveils NewDisposable Cataract Surgery Instruments II-47Bausch + Lomb Storz® Ophthalmic Instruments Unveils Tru-Size™Diamond Knife II-48Bausch & Lomb Launches the Stellaris® PC Vision EnhancementSystem for Use in Retinal Surgery II-48IRIDEX Launches New Line of Vitreoretinal Instruments II-48Nidek Launches New Varieties of Auto Lensmeters II-48Topcon Launches MS-SIO1 MicroSlit Illuminator in South America II-49

6. PRODUCT INNOVATIONS/LAUNCHES IN RECENT PAST – A PERSPECTIVE

BUILDER II-50

Paradigm Medical Introduces Surveyor 500 and Paravue 300 at AAO II-50

Reichert Launches New Tonometer II-50

Carl Zeiss Introduces Software Advancements for ATLAS® Corneal

Topography System II-50

Lumenis Unveils Cutting-Edge Ophthalmic Laser Delivery Technology II-51

Carl Zeiss Meditec Releases New Suite of Ophthalmic Solutions II-52

Ellex to Launch Advanced Ultrasound Systems and Ophthalmic Laser II-52

OIS Announces the Launch of Two New Products II-53

Topcon Unveils Advanced Corneal Analyzer II-54

Paradigm Medical Industries to Launch Ophthalmic Diagnostic

Devices II-54

Endure Introduces New Ophthalmic Surgical Microscope II-55

BD Medical – Ophthalmic Systems Launches New Knives to Treat

Astigmatism II-55

Topcon Launches Innovative SL-3G Slit Lamp II-55

Keeler Launches New Wireless Digital Indirect Ophthalmoscope II-56

Carl Zeiss Meditec Unveils Latest Ophthalmic Innovations Suite II-56

AMO Obtains U.S. FDA Clearance for Healon D® Viscoelastic II-57

Moria Launches New ‘One’ Line of One-Use Cataract Devices II-58

Kowa Optimed Launches New VK Digital Slit Lamp Imaging System II-58

Topcon Unveils TRC-NW8 Retinal Camera II-58

Topcon Launches 4-in-1 TRK-1P II-59

Topcon Unveils DC-3 Digital Camera II-59

Topcon Launches OMS-710 Surgical Microscope II-59

Carl Zeiss Meditec Rolls Out Humphrey Field Analyzer II-i II-59

Carl Zeiss Launches VisuMax® laser system II-60

Zecotek Photonics Introduces SL 1.4 Fiber Coupled Laser II-60

DRE Rolls Out Om2100 Ophthalmic Microscope II-60

Carl Zeiss Unveils i-Scription® Solution II-60

7. RECENT INDUSTRY ACTIVITY II-61Optomed Secures Japanese Ninsho Medical Device Certificationfor Optomed M5 Handheld Retinal Camera II-61Bioptigen Secures FDA Clearance to Market Envisu SpectralDomain Ophthalmic Imaging System in US II-61OptiMedica Installs Catalys Precision Laser System at MultipleClinics in Japan II-61Carl Zeiss Meditec Plans to Commence Clinical Trials of theReLEx® Smile Technique II-62Cutera Takes Over Aesthetic Business of IRIDEX II-62IRIDEX Declares Clinical Study Results of IRIDEX MicroPulse™Laser Therapy II-62US FDA Clears OptiMedica’s Catalys™ Precision Laser System II-63IRIDEX and Alcon Ink License and Distribution Agreement II-63Lumenis, Optovue and Kowa-Optimed Form Alliance in the US II-63Lumenis and Dual Laser Ink Business Cooperation and ProductDistribution Agreement II-64OPKO Health Divests Ophthalmic Instrumentation Business to Optos II-64Competitive Technologies and BiCOM Ink Strategic MarketingAgreement II-64Diagnos Inks Agreement with IRIS for CARA Commercialization II-64Heidelberg Establishes New Subsidiary Unit II-65Diagnos and Leahander Trading Ink New CARA Distribution Agreement II-65Canon Secures FDA Clearance for TX-20 Full Auto Tonometer II-65Diagnos Receives FDA Clearance for Cara Technology II-65Kowa Optimed to Establish Subsidiary in the UK II-66Technolas Perfect Vision Secures CE Mark Approval forSUPRACOR™ Presbyopia Laser Treatment II-66DuPage Medical Group Selects Merge Eye Care Suite and MergeiConnect Access II-66Novartis Takes Over Majority Stake in Alcon II-66Topcon Relocates Headquarters II-67Ellex and CenterVue Ink Distribution Agreement II-67Nidek Establishes NIDEK EYECARE DO BRASIL COMERCIO DEINSTRUMENTOS OPTICOS LTDA II-68Nidek Establishes Representative Office in Shanghai II-68Eyefinity®/OfficeMate® Enters into Partnership with Nidek II-68Keeler and Topcon Sign Distribution Agreement II-68Diagnos and Medical Technology Service Providers SignPartnership Agreement II-69

8. CORPORATE ACTIVITY IN RECENT PAST – A PERSPECTIVE BUILDER II-70

Alcon Takes Over Israeli Company Optonol II-70

Ophthalmic Imaging Wins FDA Approval for OIS EyeScan II-70

Kowa Optimed Receives FDA Approval for 3 Ophthalmic Imaging

Devices II-70

Reichert Acquires Foresee PHP® from Notal Vision II-71

DIAGNOS Agrees to Launch Pilot Project with CZC II-71

Abbott to Acquire Visiogen II-72

Premier Healthcare Inks Contracts with New Suppliers II-72

Cortec Group Acquires Katena Products II-72

BiB Signs Distribution Deal with Talia II-72

Paradigm Medical and CSO Sign Global Distribution Deal II-73

Abbott Takes Over Advanced Medical Optics II-73

OPKO Secures FDA Approval for New Combination Imaging System II-73

Paradigm Medical to Market LACE’s New Glaucoma Diagnostic Device II-74

AMO Obtains FDA Approval for its Advanced Femtosecond Laser II-74

OptiMedica Signs Deal with Topcon for Distributing PASCAL II-75

Essilor Expands Operations in Eastern Europe II-75

Bausch & Lomb Acquires eyeonics II-75

Advanced Medical Optics and Bausch & Lomb Ink Patent Agreement II-75

STAAR Surgical Acquires Stake in Canon Staar II-76

Ellex Medical Lasers Completes the Acquisition of Innovative

Imaging II-76

OccuLogix Acquires Stake in OcuSense II-76

OPKO Health Acquires Ophthalmic Technologies II-76

Affiliates of Warburg Pincus Complete the Acquisition of

Bausch & Lomb II-77

Reichert Acquires Pachymeter Products from Portable Ophthalmic

Devices II-77

OccuLogix Completes SOLX Acquisition II-77

Carl Zeiss Acquires Acri.Tec II-77

Volk Optical Signs two Distribution Agreements with Synergetics II-77

Nidek Commences a New Plant in Italy II-78

OptiMedica Enters into a Distribution Agreement with Topcon

Europe Medical II-78

Topcon Obtains FDA Approval for its 3D OCT-1000 II-78

Essilor of America Takes Over Majority Interest in OOGP II-78

Froptix, Acuity and eXegenics Merge to Form Opko Corporation II-78

NIDEK Obtains FDA Approval for ORION Auto-Retinal Imaging Device II-79

Ellex Obtains FDA Approval for Marketing 30XL Laser Slit Lamp II-79

Optos Enters into an Agreement with Pearl Vision II-79

IRIDEX and Synergetics Settle All Litigations II-79

Ellex Forays into Chinese Ophthalmic Laser Market II-80

Advanced Medical Optics Acquires IntraLase II-80

Advanced Medical Optics Takes Over WaveFront Sciences II-80

Bausch & Lomb Invests in AcuFocus II-81

Gebauer Establishes Subsidiary in the US II-81

9. FOCUS ON SELECT GLOBAL PLAYERS II-82Abbott Medical Optics, Inc. (US) II-82Alcon, Inc. (Corporate Headquarters – Switzerland) II-82Bausch & Lomb, Inc. (US) II-83Carl Zeiss Meditec AG (Germany) II-83Ellex Medical Lasers Limited (Australia) II-84Iridex Corp. (US) II-84Lumenis Ltd. (Israel) II-85Nidek Co. Ltd. (Japan) II-85Topcon Corp. (Japan) II-86Topcon Medical Systems, Inc. (US) II-86

10. GLOBAL MARKET PERSPECTIVE II-87

I. Unit Analytics II-87

Table 11: World Recent Past, Current & Future Analysis for

Ophthalmic Instrumentation by Geographic Region – US, Canada,

Japan, Europe, Asia-Pacific, the Middle East, and Latin

America Markets Independently Analyzed with Annual Sales

Figures in Units for Years 2010 through 2018 (includes

corresponding Graph/Chart) II-87

Table 12: World Historic Review for OphthalmicInstrumentation by Geographic Region – US, Canada, Japan,Europe, Asia-Pacific, the Middle East, and Latin AmericaMarkets Independently Analyzed with Annual Sales Figures inUnits for Years 2004 through 2009 (includes correspondingGraph/Chart) II-88

Table 13: World 15-Year Perspective for Ophthalmic

Instrumentation by Geographic Region – Percentage Breakdown

of Volume Sales for US, Canada, Japan, Europe, Asia-Pacific,

the Middle East, and Latin America Markets for Years 2004,

2011 & 2018 (includes corresponding Graph/Chart) II-89

Ophthalmic Instrumentation Market by Product Group/Segment II-90

Table 14: World Recent Past, Current & Future Analysis for

Ophthalmic Instrumentation by Product Group – Ophthalmic

Diagnostic Devices and Ophthalmic Surgical Products Markets

Independently Analyzed with Annual Sales Figures in Units for

Years 2010 through 2018 (includes corresponding Graph/Chart) II-90

Table 15: World Historic Review for OphthalmicInstrumentation by Product Group – Ophthalmic DiagnosticDevices and Ophthalmic Surgical Products MarketsIndependently Analyzed with Annual Sales Figures in Units forYears 2004 through 2009 (includes corresponding Graph/Chart) II-91

Table 16: World 15-Year Perspective for Ophthalmic

Instrumentation by Product Group – Percentage Breakdown of

Volume Sales for Ophthalmic Diagnostic Devices and Ophthalmic

Surgical Products Markets for Years 2004, 2011 & 2018

(includes corresponding Graph/Chart) II-92

Ophthalmic Diagnostic Devices II-93

Table 17: World Recent Past, Current & Future Analysis for

Ophthalmic Diagnostic Devices by Geographic Region – US,

Canada, Japan, Europe, Asia-Pacific, the Middle East, and

Latin America Markets Independently Analyzed with Annual

Sales Figures in Units for Years 2010 through 2018 (includes

corresponding Graph/Chart) II-93

Table 18: World Historic Review for Ophthalmic DiagnosticDevices by Geographic Region – US, Canada, Japan, Europe,Asia-Pacific, the Middle East, and Latin America MarketsIndependently Analyzed with Annual Sales Figures in Units forYears 2004 through 2009 (includes corresponding Graph/Chart) II-94

Table 19: World 15-Year Perspective for Ophthalmic Diagnostic

Devices by Geographic Region – Percentage Breakdown of Volume

Sales for US, Canada, Japan, Europe, Asia-Pacific, the Middle

East, and Latin America Markets for Years 2004, 2011 & 2018

(includes corresponding Graph/Chart) II-95

Table 20: World Recent Past, Current & Future Analysis forOphthalmic Diagnostic Devices by Product Segment -Ophthalmoscopes, Lens Meters, Slit Lamps, Tonometers,Perimeters, Corneal Topography Systems, Refractors,Diagnostic Imaging Systems, Fundus Cameras, and DiagnosticUltrasound Equipment Markets Independently Analyzed withAnnual Sales Figures in Units for Years 2010 through 2018(includes corresponding Graph/Chart) II-96

Table 21: World Historic Review for Ophthalmic Diagnostic

Devices by Product Segment – Ophthalmoscopes, Lens Meters,

Slit Lamps, Tonometers, Perimeters, Corneal Topography

Systems, Refractors, Diagnostic Imaging Systems, Fundus

Cameras, and Diagnostic Ultrasound Equipment Markets

Independently Analyzed with Annual Sales Figures in Units for

Years 2004 through 2009 (includes corresponding Graph/Chart) II-97

Table 22: World 15-Year Perspective for Ophthalmic DiagnosticDevices by Product Segment – Percentage Breakdown of VolumeSales for Ophthalmoscopes, Lens Meters, Slit Lamps,Tonometers, Perimeters, Corneal Topography Systems,Refractors, Diagnostic Imaging Systems, Fundus Cameras, andDiagnostic Ultrasound Equipment Markets for Years 2004, 2011& 2018 (includes corresponding Graph/Chart) II-98Ophthalmic Surgical Products II-99Table 23: World Recent Past, Current & Future Analysis forOphthalmic Surgical Devices by Geographic Region – US,Canada, Japan, Europe, Asia-Pacific, the Middle East, andLatin America Markets Independently Analyzed with AnnualSales Figures in Units for Years 2010 through 2018 (includescorresponding Graph/Chart) II-99

Table 24: World Historic Review for Ophthalmic Surgical

Devices by Geographic Region – US, Canada, Japan, Europe,

Asia-Pacific, the Middle East, and Latin America Markets

Independently Analyzed with Annual Sales Figures in Units for

Years 2004 through 2009 (includes corresponding Graph/Chart) II-100

Table 25: World 15-Year Perspective for Ophthalmic SurgicalDevices by Geographic Region – Percentage Breakdown of VolumeSales for US, Canada, Japan, Europe, Asia-Pacific, the MiddleEast, and Latin America Markets for Years 2004, 2011 & 2018(includes corresponding Graph/Chart) II-101Ophthalmic Surgical Devices by Product Segment II-102Table 26: World Recent Past, Current & Future Analysis forOphthalmic Surgical Devices by Product Segment – OphthalmicLasers and Ophthalmic Surgical Microscopes MarketsIndependently Analyzed with Annual Sales Figures in Units forYears 2010 through 2018 (includes corresponding Graph/Chart) II-102

Table 27: World Historic Review for Ophthalmic Surgical

Devices by Product Segment – Ophthalmic Lasers and Ophthalmic

Surgical Microscopes Markets Independently Analyzed with

Annual Sales Figures in Units for Years 2004 through 2009

(includes corresponding Graph/Chart) II-103

Table 28: World 15-Year Perspective for Ophthalmic SurgicalDevices by Product Segment – Percentage Breakdown of VolumeSales for Ophthalmic Lasers and Ophthalmic SurgicalMicroscopes Markets for Years 2004, 2011 & 2018 (includescorresponding Graph/Chart) II-104II. Value Analytics II-105Table 29: World Recent Past, Current & Future Analysis forOphthalmic Instrumentation by Geographic Region – US, Canada,Japan, Europe, Asia-Pacific, the Middle East, and LatinAmerica Markets Independently Analyzed with Annual SalesFigures in US$ Thousands for Years 2010 through 2018(includes corresponding Graph/Chart) II-105

Table 30: World Historic Review for Ophthalmic

Instrumentation by Geographic Region – US, Canada, Japan,

Europe, Asia-Pacific, the Middle East, and Latin America

Markets Independently Analyzed with Annual Sales Figures in

US$ Thousands for Years 2000 through 2006 (includes

corresponding Graph/Chart) II-106

Table 31: World 15-Year Perspective for OphthalmicInstrumentation by Geographic Region – Percentage Breakdownof Value Sales for US, Canada, Japan, Europe, Asia-Pacific,the Middle East, and Latin America Markets for Years 2004,2011 & 2018 (includes corresponding Graph/Chart) II-107Analytics by Segment II-108Table 32: World Recent Past, Current & Future Analysis forOphthalmic Instrumentation by Product Segment – OphthalmicDiagnostic Devices and Ophthalmic Surgical Devices MarketsIndependently Analyzed with Annual Sales Figures in US$Thousands for Years 2010 through 2018 (includes correspondingGraph/Chart) II-108

Table 33: World Historic Review for Ophthalmic

Instrumentation by Product Segment – Ophthalmic Diagnostic

Devices and Ophthalmic Surgical Devices Markets Independently

Analyzed with Annual Sales Figures in US$ Thousands for Years

2004 through 2009 corresponding Graph/Chart) II-109

Table 34: World 15-Year Perspective for OphthalmicInstrumentation by Product Segment- Percentage Breakdown ofValue Sales for Ophthalmic Diagnostic Devices and OphthalmicSurgical Devices Markets for Years 2004, 2011 & 2018(includes corresponding Graph/Chart) II-110Ophthalmic Diagnostic Devices II-111Table 35: World Recent Past, Current & Future Analysis forOphthalmic Diagnostic Devices by Geographic Region – US,Canada, Japan, Europe, Asia-Pacific, the Middle East, andLatin America Markets Independently Analyzed with AnnualSales Figures in US$ Thousands for Years 2010 through 2018(includes corresponding Graph/Chart) II-111

Table 36: World Historic Review for Ophthalmic Diagnostic

Devices by Geographic Region – US, Canada, Japan, Europe,

Asia-Pacific, the Middle East, and Latin America Markets

Independently Analyzed with Annual Sales Figures in US$

Thousands for Years 2004 through 2009 (includes corresponding

Graph/Chart) II-112

Table 37: World 15-Year Perspective for Ophthalmic DiagnosticDevices by Geographic Region – Percentage Breakdown of ValueSales for US, Canada, Japan, Europe, Asia-Pacific, the MiddleEast, and Latin America Markets for Years 2004, 2011 & 2018(includes corresponding Graph/Chart) II-113Ophthalmic Diagnostic Devices by Segment II-114Table 38: World Recent Past, Current & Future Analysis forOphthalmic Diagnostic Devices by Product Segment – CornealTopography Systems, Lens Meters, Refractors, Ophthalmoscopes,Slit Lamps, Fundus Cameras, Perimeters, Diagnostic ImagingSystems, Tonometers, and Diagnostic Ultrasound EquipmentMarkets Independently Analyzed with Annual Sales Figures inUS$ Thousands for Years 2010 through 2018 (includescorresponding Graph/Chart) II-114

Table 39: World Historic Review for Ophthalmic Diagnostic

Devices by Product Segment – Corneal Topography Systems,

Refractors, Perimeters, Slit Lamps, Lens Meters,

Ophthalmoscopes, Fundus Cameras, Diagnostic Ultrasound

Equipment, Diagnostic Imaging Systems, and Tonometers Markets

Independently Analyzed with Annual Sales Figures in US$

Thousands for Years 2004 through 2009 (includes corresponding

Graph/Chart) II-115

Table 40: World 15-Year Perspective for Ophthalmic DiagnosticDevices by Product Segment – Percentage Breakdown of ValueSales for Corneal Topography Systems, Refractors, Perimeters,Slit Lamps, Diagnostic Ultrasound Equipment, Lens Meters,Fundus Cameras, Diagnostic Imaging Systems, Ophthalmoscopes,and Tonometers Markets for Years 2004, 2011 & 2018 (includescorresponding Graph/Chart) II-116Ophthalmic Surgical Devices II-117Table 41: World Recent Past, Current & Future Analysis forOphthalmic Surgical Devices by Geographic Region – US,Canada, Japan, Europe, Asia-Pacific, the Middle East, andLatin America Markets Independently Analyzed with AnnualSales Figures in US$ Thousands for Years 2010 through 2018(includes corresponding Graph/Chart) II-117

Table 42: World Historic Review for Ophthalmic Surgical

Devices by Geographic Region – US, Canada, Japan, Europe,

Asia-Pacific, the Middle East, and Latin America Markets

Independently Analyzed with Annual Sales Figures in US$

Thousands for Years 2004 through 2009 (includes corresponding

Graph/Chart) II-118

Table 43: World 15-Year Perspective for Ophthalmic SurgicalDevices by Geographic Region – Percentage Breakdown of ValueSales for US, Canada, Japan, Europe, Asia-Pacific, the MiddleEast, and Latin America Markets for Years 2004, 2011 & 2018(includes corresponding Graph/Chart) II-119Ophthalmic Surgical Devices By Segment II-120Table 44: World Recent Past, Current & Future Analysis forOphthalmic Surgical Devices by Product Segment – OphthalmicDisposables, Ophthalmic Lasers, and Ophthalmic SurgicalMicroscopes Markets Independently Analyzed with Annual SalesFigures in US$ Thousands for Years 2010 through 2018(includes corresponding Graph/Chart) II-120

Table 45: World Historic Review for Ophthalmic Surgical

Devices by Product Segment – Ophthalmic Disposables,

Ophthalmic Lasers, and Ophthalmic Surgical Microscopes

Markets Independently Analyzed with Annual Sales Figures in

US$ Thousands for Years 2004 through 2009 (includes

corresponding Graph/Chart) II-121

Table 46: World 15-Year Perspective for Ophthalmic SurgicalDevices by Product Segment – Percentage Breakdown of ValueSales for Ophthalmic Disposables, Ophthalmic Lasers, andOphthalmic Surgical Microscopes Markets for Years 2004, 2011& 2018 (includes corresponding Graph/Chart) II-122III. MARKET

1. THE UNITED STATES III-1

A.Market Analysis III-1

Outlook III-1

Growth Drivers III-1

Fact File III-2

Ophthalmic Marketers to Catch Up on Ageing ‘Baby Boomers’ III-2

Alternative Procedures to Offer Growth Prospects III-3

Femtolasers Open New Ground for Cataract Surgery III-3

Trade Statistics III-4

Exports III-4

Table 47: US Exports of Ophthalmic Instruments and

Appliances (2009 & 2010): Percentage Share Breakdown of

Export Value by Destination Country (includes

corresponding Graph/Chart) III-4

Imports III-5

Table 48: US Imports of Ophthalmic Instruments and

Appliances (2009 & 2010): Percentage Share Breakdown of

Import Value by Source Country (includes corresponding

Graph/Chart) III-5

Statistical Findings On Ophthalmic Diseases in the United

States III-5

Table 49: Prevalence of Age-Related Wet Macular

Degeneration in the United States for the Years 2006, 2009, &

2012 (In Millions of Individuals) (includes corresponding

Graph/Chart) III-5

Table 50: Number of Individuals Treated for Wet AMD in theUnited States (In Thousands) for the Years 2006, 2009 &2012 (includes corresponding Graph/Chart) III-6

Table 51: Prevalence of Ocular Hypertension (OHT) in the

United States for the Years 2006, 2009, & 2011 (In Millions

of Individuals) (includes corresponding Graph/Chart) III-6

Table 52: Prevalence of Primary Open Angle Glaucoma (POAG)in the United States for the Years 2006, 2009, & 2011 (InMillions of Individuals) (includes correspondingGraph/Chart) III-6

Table 53: Number of Individuals Treated for Glaucoma in the

United Sates (2006, 2009 and 2011): Breakdown by Type -

Ocular Hypertension (OHT), Primary Open Angle Glaucoma

(POAG), Normal Tension Glaucoma (NTG), Pigmentary Glaucoma

(PG) and Exfoliative Glaucoma (EG) (In 000 Individuals)

(includes corresponding Graph/Chart) III-7

Table 54: Prevalence of Cataract in the United States forthe Years 2006, 2009 & 2012 (In Millions of Individuals)(includes corresponding Graph/Chart) III-7Product Introductions/Developments III-8Strategic Corporate Developments III-10Key Players III-14B.Market Analytics III-17I. Unit Analytics III-17Table 55: The US Recent Past, Current & Future Analysis forOphthalmic Instrumentation by Product Group/Segment -Diagnostic Devices (Corneal Topography Systems, Refractors,Perimeters, Slit Lamps, Diagnostic Ultrasound Equipment,Lens Meters, Fundus Cameras, Diagnostic Imaging Systems,Ophthalmoscopes, and Tonometers) and Surgical ProductsMarkets Independently Analyzed with Annual Sales Figures inUnits for Years 2010 through 2018 (includes correspondingGraph/Chart) III-17

Table 56: The US Historic Review for Ophthalmic

Instrumentation by Product Group/Segment – Diagnostic

Devices (Corneal Topography Systems, Refractors,

Perimeters, Slit Lamps, Diagnostic Ultrasound Equipment,

Lens Meters, Fundus Cameras, Diagnostic Imaging Systems,

Ophthalmoscopes, and Tonometers) and Surgical Products

Markets Independently Analyzed with Annual Sales Figures in

Units for Years 2004 through 2009 (includes corresponding

Graph/Chart) III-18

Table 57: The US 15-Year Perspective for OphthalmicInstrumentation by Product Group/Segment – PercentageBreakdown of Volume Sales for Diagnostic Devices (CornealTopography Systems, Refractors, Perimeters, Slit Lamps,Diagnostic Ultrasound Equipment, Lens Meters, FundusCameras, Diagnostic Imaging Systems, Ophthalmoscopes, andTonometers) and Surgical Products Markets for 2004, 2011 &2018 (includes corresponding Graph/Chart) III-19II. Value Analytics III-20Table 58: The US Recent Past, Current & Future Analysis forOphthalmic Instrumentation by Product Group/Segment -Diagnostic Devices (Corneal Topography Systems, Refractors,Perimeters, Slit Lamps, Diagnostic Ultrasound Equipment,Lens Meters, Fundus Cameras, Diagnostic Imaging Systems,Ophthalmoscopes, and Tonometers) and Surgical Products(Ophthalmic Disposables, Ophthalmic Lasers, and OphthalmicSurgical Microscope) Markets Independently Analyzed withAnnual Sales Figures in US$ Thousands for Years 2010through 2018 (includes corresponding Graph/Chart) III-20

Table 59: The US Historic Review for Ophthalmic

Instrumentation by Product Group/Segment – Diagnostic

Devices (Corneal Topography Systems, Refractors,

Perimeters, Slit Lamps, Diagnostic Ultrasound Equipment,

Lens Meters, Fundus Cameras, Diagnostic Imaging Systems,

Ophthalmoscopes, and Tonometers) and Surgical Products

(Ophthalmic Disposables, Ophthalmic Lasers, and Ophthalmic

Surgical Microscope) Markets Independently Analyzed with

Annual Sales Figures in US$ Thousands for Years 2004

through 2009 (includes corresponding Graph/Chart) III-21

Table 60: The US 15-Year Perspective for OphthalmicInstrumentation by Product Group/Segment – PercentageBreakdown of Value Sales for Diagnostic Devices (CornealTopography Systems, Refractors, Perimeters, Slit Lamps,Diagnostic Ultrasound Equipment, Lens Meters, FundusCameras, Diagnostic Imaging Systems, Ophthalmoscopes, andTonometers) and Surgical Products (Ophthalmic Disposables,Ophthalmic Lasers, and Ophthalmic Surgical Microscope)Markets for 2004, 2011 & 2018 (includes correspondingGraph/Chart) III-22

2. CANADA III-23

A.Market Analysis III-23

Outlook III-23

Trade Statistics III-23

Exports III-23

Table 61: Canadian Exports of Ophthalmic Instruments and

Appliances (2009 & 2010): Percentage Share Breakdown of

Export Value by Destination Country (includes

corresponding Graph/Chart) III-23

Imports III-24

Table 62: Canadian Imports of Ophthalmic Instruments and

Appliances (2009 & 2010): Percentage Share Breakdown of

Import Value by Source Country (includes corresponding

Graph/Chart) III-24

B.Market Analytics III-25

I. Unit Analytics III-25

Table 63: Canadian Recent Past, Current & Future Analysis

for Ophthalmic Instrumentation by Product Group/Segment -

Diagnostic Devices (Corneal Topography Systems, Refractors,

Perimeters, Slit Lamps, Diagnostic Ultrasound Equipment,

Lens Meters, Fundus Cameras, Diagnostic Imaging Systems,

Ophthalmoscopes, and Tonometers) and Surgical Products

Markets Independently Analyzed with Annual Sales Figures in

Units for Years 2010 through 2018 (includes corresponding

Graph/Chart) III-25

Table 64: Canadian Historic Review for OphthalmicInstrumentation by Product Group/Segment – DiagnosticDevices (Corneal Topography Systems, Refractors,Perimeters, Slit Lamps, Diagnostic Ultrasound Equipment,Lens Meters, Fundus Cameras, Diagnostic Imaging Systems,Ophthalmoscopes, and Tonometers) and Surgical ProductsMarkets Independently Analyzed with Annual Sales Figures inUnits for Years 2004 through 2009 (includes correspondingGraph/Chart) III-26

Table 65: Canadian 15-Year Perspective for Ophthalmic

Instrumentation by Product Group/Segment – Percentage

Breakdown of Volume Sales for Diagnostic Devices (Corneal

Topography Systems, Refractors, Perimeters, Slit Lamps,

Diagnostic Ultrasound Equipment, Lens Meters, Fundus

Cameras, Diagnostic Imaging Systems, Ophthalmoscopes, and

Tonometers) and Surgical Products Markets for 2004, 2011 &

2018 (includes corresponding Graph/Chart) III-27

II. Value Analytics III-28

Table 66: Canadian Recent Past, Current & Future Analysis

for Ophthalmic Instrumentation by Product Group/Segment -

Diagnostic Devices (Corneal Topography Systems, Refractors,

Perimeters, Slit Lamps, Diagnostic Ultrasound Equipment,

Lens Meters, Fundus Cameras, Diagnostic Imaging Systems,

Ophthalmoscopes, and Tonometers) and Surgical Products

(Ophthalmic Disposables, Ophthalmic Lasers, and Ophthalmic

Surgical Microscope) Markets Independently Analyzed with

Annual Sales Figures in US$ Thousands for Years 2010

through 2018 (includes corresponding Graph/Chart) III-28

Table 67: Canadian Historic Review for OphthalmicInstrumentation by Product Group/Segment – DiagnosticDevices (Corneal Topography Systems, Refractors,Perimeters, Slit Lamps, Diagnostic Ultrasound Equipment,Lens Meters, Fundus Cameras, Diagnostic Imaging Systems,Ophthalmoscopes, and Tonometers) and Surgical Products(Ophthalmic Disposables, Ophthalmic Lasers, and OphthalmicSurgical Microscope) Markets Independently Analyzed withAnnual Sales Figures in US$ Thousands for Years 2004through 2009 (includes corresponding Graph/Chart) III-29

Table 68: Canadian 15-Year Perspective for Ophthalmic

Instrumentation by Product Group/Segment – Percentage

Breakdown of Value Sales for Diagnostic Devices (Corneal

Topography Systems, Refractors, Perimeters, Slit Lamps,

Diagnostic Ultrasound Equipment, Lens Meters, Fundus

Cameras, Diagnostic Imaging Systems, Ophthalmoscopes, and

Tonometers) and Surgical Products (Ophthalmic Disposables,

Ophthalmic Lasers, and Ophthalmic Surgical Microscope)

Markets for Years 2004, 2011 & 2018 (includes corresponding

Graph/Chart) III-30

3. JAPAN III-31A.Market Analysis III-31Strategic Corporate Developments III-31Select Players III-33B.Market Analytics III-35I. Unit Analytics III-35Table 69: Japanese Recent Past, Current & Future Analysisfor Ophthalmic Instrumentation by Product Group/Segment -Diagnostic Devices (Corneal Topography Systems, Refractors,Perimeters, Slit Lamps, Diagnostic Ultrasound Equipment,Lens Meters, Fundus Cameras, Diagnostic Imaging Systems,Ophthalmoscopes, and Tonometers) and Surgical ProductsMarkets Independently Analyzed with Annual Sales Figures inUnits for Years 2010 through 2018 (includes correspondingGraph/Chart) III-35

Table 70: Japanese Historic Review for Ophthalmic

Instrumentation by Product Group/Segment – Diagnostic

Devices (Corneal Topography Systems, Refractors,

Perimeters, Slit Lamps, Diagnostic Ultrasound Equipment,

Lens Meters, Fundus Cameras, Diagnostic Imaging Systems,

Ophthalmoscopes, and Tonometers) and Surgical Products

Markets Independently Analyzed with Annual Sales Figures in

Units for Years 2004 through 2009 (includes corresponding

Graph/Chart) III-36

Table 71: Japanese 15-Year Perspective for OphthalmicInstrumentation by Product Group/Segment – PercentageBreakdown of Volume Sales for Diagnostic Devices (CornealTopography Systems, Refractors, Perimeters, Slit Lamps,Diagnostic Ultrasound Equipment, Lens Meters, FundusCameras, Diagnostic Imaging Systems, Ophthalmoscopes, andTonometers) and Surgical Products Markets for 2004, 2011 &2018 (includes corresponding Graph/Chart) III-37II. Value Analytics III-38Table 72: Japanese Recent Past, Current & Future Analysisfor Ophthalmic Instrumentation by Product Group/Segment -Diagnostic Devices (Corneal Topography Systems, Refractors,Perimeters, Slit Lamps, Diagnostic Ultrasound Equipment,Lens Meters, Fundus Cameras, Diagnostic Imaging Systems,Ophthalmoscopes, and Tonometers) and Surgical Products(Ophthalmic Disposables, Ophthalmic Lasers, and OphthalmicSurgical Microscope) Markets Independently Analyzed withAnnual Sales Figures in US$ Thousands for Years 2010through 2018 (includes corresponding Graph/Chart) III-38

Table 73: Japanese Historic Review for Ophthalmic

Instrumentation by Product Group/Segment – Diagnostic

Devices (Corneal Topography Systems, Refractors,

Perimeters, Slit Lamps, Diagnostic Ultrasound Equipment,

Lens Meters, Fundus Cameras, Diagnostic Imaging Systems,

Ophthalmoscopes, and Tonometers) and Surgical Products

(Ophthalmic Disposables, Ophthalmic Lasers, and Ophthalmic

Surgical Microscope) Markets Independently Analyzed with

Annual Sales Figures in US$ Thousands for Years 2004

through 2009 (includes corresponding Graph/Chart) III-39

Table 74: Japanese 15-Year Perspective for OphthalmicInstrumentation by Product Group/Segment – PercentageBreakdown of Value Sales for Diagnostic Devices (CornealTopography Systems, Refractors, Perimeters, Slit Lamps,Diagnostic Ultrasound Equipment, Lens Meters, FundusCameras, Diagnostic Imaging Systems, Ophthalmoscopes, andTonometers) and Surgical Products (Ophthalmic Disposables,ophthalmic Lasers, and Ophthalmic Surgical Microscope)Markets for 2004, 2011 & 2018 (includes correspondingGraph/Chart) III-40

4. EUROPE III-41

A.Market Analysis III-41

Outlook III-41

Refractive Surgery Market III-41

Select Players III-41

Product launches/ developments III-43

Strategic corporate developments III-43

B.Market Analytics III-46

I. Unit Analytics III-46

Table 75: European Recent Past, Current & Future Analysis

for Ophthalmic Instrumentation by Geographic Region -

France, Germany, Italy, UK, Spain, Russia & Rest of Europe

Markets Independently Analyzed with Annual Sales Figures in

Units for Years 2010 through 2018 (includes corresponding

Graph/Chart) III-46

Table 76: European Historic Review for OphthalmicInstrumentation by Geographic Region – France, Germany,Italy, UK, Spain, Russia & Rest of Europe MarketsIndependently Analyzed with Annual Sales Figures in Unitsfor Years 2004 through 2009 (includes correspondingGraph/Chart) III-47

Table 77: European 15-Year Perspective for Ophthalmic

Instrumentation by Geographic Region – Percentage Breakdown

of Volume Sales for France, Germany, Italy, UK, Spain,

Russia & Rest of Europe Markets for Years 2004, 2011 & 2018

(includes corresponding Graph/Chart) III-48

Table 78: European Recent Past, Current & Future Analysisfor Ophthalmic Instrumentation by Product Group/Segment -Diagnostic Devices (Corneal Topography Systems, Refractors,Perimeters, Slit Lamps, Diagnostic Ultrasound Equipment,Lens Meters, Fundus Cameras, Diagnostic Imaging Systems,Ophthalmoscopes, and Tonometers) and Surgical ProductsMarkets Independently Analyzed with Annual Sales Figures inUnits for Years 2010 through 2018 (includes correspondingGraph/Chart) III-49

Table 79: European Historic Review for Ophthalmic

Instrumentation by Product Group/Segment – Diagnostic

Devices (Corneal Topography Systems, Refractors,

Perimeters, Slit Lamps, Diagnostic Ultrasound Equipment,

Lens Meters, Fundus Cameras, Diagnostic Imaging Systems,

Ophthalmoscopes, and Tonometers) and Surgical Products

Markets Independently Analyzed with Annual Sales Figures in

Units for Years 2004 through 2009 (includes corresponding

Graph/Chart) III-50

Table 80: European 15-Year Perspective for OphthalmicInstrumentation by Product Group/Segment – PercentageBreakdown of Volume Sales for Diagnostic Devices (CornealTopography Systems, Refractors, Perimeters, Slit Lamps,Diagnostic Ultrasound Equipment, Lens Meters, FundusCameras, Diagnostic Imaging Systems, Ophthalmoscopes, andTonometers) and Surgical Products Markets for 2004, 2011 &2018 (includes corresponding Graph/Chart) III-51II. Value Analytics III-52Table 81: European Recent Past, Current & Future Analysisfor Ophthalmic Instrumentation by Geographic Region -France, Germany, Italy, UK, Spain, Russia & Rest of EuropeMarkets Independently Analyzed with Annual Sales Figures inUS$ Thousands for Years 2010 through 2018 (includescorresponding Graph/Chart) III-52

Table 82: European Historic Review for Ophthalmic

Instrumentation by Geographic Region – France, Germany,

Italy, UK, Spain, Russia & Rest of Europe Markets

Independently Analyzed with Annual Sales Figures in US$

Thousands for Years 2004 through 2009 (includes

corresponding Graph/Chart) III-53

Table 83: European 15-Year Perspective for OphthalmicInstrumentation by Geographic Region – Percentage Breakdownof Value Sales for France, Germany, Italy, UK, Spain,Russia & Rest of Europe Markets for Years 2004, 2011 & 2018(includes corresponding Graph/Chart) III-54

Table 84: European Recent Past, Current & Future Analysis

for Ophthalmic Instrumentation by Product Group/Segment -

Diagnostic Devices (Corneal Topography Systems, Refractors,

Perimeters, Slit Lamps, Diagnostic Ultrasound Equipment,

Lens Meters, Fundus Cameras, Diagnostic Imaging Systems,

Ophthalmoscopes, and Tonometers) and Surgical Products

(Ophthalmic Disposables, Ophthalmic Lasers, and Ophthalmic

Surgical Microscope) Markets Independently Analyzed with

Annual Sales Figures in US$ Thousands for Years 2010

through 2018 (includes corresponding Graph/Chart) III-55

Table 85: European Historic Review for OphthalmicInstrumentation by Product Group/Segment – DiagnosticDevices (Corneal Topography Systems, Refractors,Perimeters, Slit Lamps, Diagnostic Ultrasound Equipment,Lens Meters, Fundus Cameras, Diagnostic Imaging Systems,Ophthalmoscopes, and Tonometers) and Surgical Products(Ophthalmic Disposables, Ophthalmic Lasers, and OphthalmicSurgical Microscope) Markets Independently Analyzed withAnnual Sales Figures in US$ Thousands for Years 2004through 2009 (includes corresponding Graph/Chart) III-56

Source : http://www.news-medical.net/news/20121203/Research-report-on-global-ophthalmic-instrumentation-industry.aspx

Full story

Neusoft Medical receives FDA 510k clearance for NeuViz 64 multi-slice CT scanner

Neusoft Medical receives FDA 510k clearance for NeuViz 64 multi-slice CT scanner

Neusoft Medical Systems Co., Ltd. (“Neusoft Medical”), a wholly-owned subsidiary of Neusoft Corporation, announced today that the NeuViz 64 multi-slice CT scanner has received FDA 510k clearance. The 64-slice CT scanner was developed independently by Neusoft Medical and debuted globally at the 2011 Radiological Society of North America (RSNA) Conference and the 67th China International Medical Equipment Fair (CMEF) in Spring 2012.

Neusoft Medical has pioneered the rapid evolution of CT technology to meet the global demand for high-quality, affordable imaging. The NeuViz 64 provides a clinical and financial solution for the currently challenged paradigm which places the clinical advantages of 64-slice scanning beyond the financial budget of most hospitals and imaging centers. The NeuViz 64 design delivers low-dose scanning, high patient throughput, ease of use, performs advanced Cardiac Imaging, and provides for a wide variety of clinically-relevant post processing and diagnostic techniques.

Commenting from the 98th RSNA Conference, Christopher McHan, President of Neusoft Medical Systems USA said, “The FDA approval of the NeuViz 64 CT further validates Neusoft Medical’s capacity to introduce high quality technology that meets the requirements of clinical practice around the world. Of equal importance during healthcare reform, Neusoft research, development and manufacturing capabilities enable unprecedented economic feasibility for healthcare providers to purchase and utilize the latest diagnostic imaging tools.”

Neusoft Medical continues to expand its global presence around the world including a rapidly growing installed base in North America. Neusoft Medical has achieved ISO9001 Quality System Certification for all products, among which, CT, MRI, X-ray, diagnostic ultrasound and PET products have been certified by CE and FDA. The addition of a 64-slice scanner complements a full suite of Neusoft Medical CT systems available in over 60 countries including the NeuViz Single, NeuViz Dual, NeuViz 16 and now the NeuViz 64.

Source : http://www.news-medical.net/news/20121127/Neusoft-Medical-receives-FDA-510k-clearance-for-NeuViz-64-multi-slice-CT-scanner.aspx

Full story

Siemens introduces ACUSON Freestyle ultrasound system with wireless transducers at RSNA 2012

Siemens introduces ACUSON Freestyle ultrasound system with wireless transducers at RSNA 2012

At the 98th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), November 25-30 in Chicago, Siemens Healthcare (Booth #831, East Building/Lakeside Center at McCormick Place, Hall D) is introducing the ACUSON Freestyle™ ultrasound system that features wireless transducers, eliminating the impediment of cables in ultrasound imaging. To enable this pioneering technology, the system brings to the market a large number of innovations, including acoustics, system architecture, radio design, miniaturization, and image processing. The ACUSON Freestyle system will expand ultrasound’s use in interventional and therapeutic applications, where the technology provides numerous workflow and image quality advantages. The development of wireless ultrasound is in line with the objectives of the Healthcare Sector’s global initiative Agenda 2013 – specifically in the areas of innovation and accessibility.

“Siemens Healthcare is the first company to introduce an ultrasound system that enables physicians to work with cable-free transducers”

Transducer cables have always been a cumbersome necessity in ultrasound imaging. Not only are they an impediment to fast and ergonomic examination procedures, but they also present an infection control risk in sterile interventional settings, even when they are covered in sterile sheaths. “Siemens Healthcare is the first company to introduce an ultrasound system that enables physicians to work with cable-free transducers,” says Jeffrey Bundy, CEO of the Siemens Healthcare Ultrasound business unit. “The ACUSON Freestyle system facilitates the use of advanced ultrasound technology into clinical fields requiring a sterile environment, such as interventional radiology, anesthesiology, critical care, cath lab, or emergency care.” Wireless transducers can also expand ultrasound into new and emerging applications such as administering nerve blocks, enhancing vascular access, and improving target localization through ultrasound guidance during therapeutic interventions and biopsies.

For image acquisition and processing, the ACUSON Freestyle system employs advanced synthetic aperture imaging technology, an integration of proprietary hardware and software that was specifically developed for the wireless signal transmission of full-resolution digital image data at very high data rates. Focusing on each pixel in the image, this method produces excellent image quality throughout the field of view. This design reduces the transducer’s power requirements, increasing battery life. Wireless real-time ultrasound data transmission is further enabled through the proprietary development of a novel ultra-wideband radio technology, which, operating at a high frequency of 7.8 Gigahertz, is not susceptible to interference with other electronic equipment.

Three wireless transducers are available for the ACUSON Freestyle system, covering a range of general imaging, vascular, and high-frequency applications such as musculoskeletal and nerve imaging. The user can operate the transducers up to three meters away from the system, which includes an ergonomic interface that enables remote control of scanning parameters from within the sterile field. The ACUSON Freestyle system has a 38-centimeter, high-resolution LED display. The system console can be mounted easily on a lightweight cart and also operates on battery power.

The products mentioned here are not commercially available in all countries. Due to regulatory reasons the future availability in any country cannot be guaranteed. Further details are available from the local Siemens organizations.

Launched by Siemens Healthcare Sector in November 2011, Agenda 2013 is a two-year global initiative to further strengthen the Healthcare Sector’s innovative power and competitiveness. Specific measures will be implemented in four fields of action: Innovation, Competitiveness, Regional Footprint, and People Development.

Source : http://www.news-medical.net/news/20121126/Siemens-introduces-ACUSON-Freestyle-ultrasound-system-with-wireless-transducers-at-RSNA-2012.aspx

Full story

Tirofiban effectively prevents strokes in high risk patients

Tirofiban effectively prevents strokes in high risk patients

Scientists may have discovered a new way to prevent strokes in high risk patients, according to research from the University of Warwick and University Hospitals Coventry and Warwickshire (UHCW).

Work by a new research group, led by Professor Donald Singer, Professor of Therapeutics at Warwick Medical School and Professor Chris Imray from UHCW, has now been published in US journal Stroke.

The group is using ultrasound scanning to look at patients with carotid artery disease, one of the major causes of stroke. Clots can form on diseased carotid arteries in the neck. Small parts of these clots can released to form microemboli, which can travel to block key brain arteries and lead to weakness, disturbed speech, loss of vision and other serious stroke syndromes. Standard anti-platelet drugs such as aspirin may not prevent the formation of harmful microemboli.

The scanning process can be used to find patients at very high risk of stroke because microemboli have formed despite prior anti-platelet drugs. Using scanning, the team has found that tirofiban, another anti-platelet drug designed to inhibit the formation of blood clots, can suppress microemboli where previous treatment such as aspirin has been ineffective. In their study, tirofiban was more effective than other ‘rescue’ treatment.

Professor Singer said: “These findings show that the choice of rescue medicine is very important when carotid patients develop microemboli despite previous treatment with powerful anti-platelet drugs such as aspirin. We now need to go on to further studies of anti-microemboli rescue treatments, to aim for the right balance between protection and risk for our patients.”

Professor Imray said: “These findings show the importance of ultrasound testing for micro-emboli in carotid disease patients. These biomarkers of high stroke risk cannot be predicted just from assessing the severity of risk factors such as smoking history, cholesterol and blood pressure.”

Source : http://www.news-medical.net/news/20121122/Tirofiban-effectively-prevents-strokes-in-high-risk-patients.aspx

Full story

Tirofiban effectively prevents strokes in high risk patients

Tirofiban effectively prevents strokes in high risk patients

Scientists may have discovered a new way to prevent strokes in high risk patients, according to research from the University of Warwick and University Hospitals Coventry and Warwickshire (UHCW).

Work by a new research group, led by Professor Donald Singer, Professor of Therapeutics at Warwick Medical School and Professor Chris Imray from UHCW, has now been published in US journal Stroke.

The group is using ultrasound scanning to look at patients with carotid artery disease, one of the major causes of stroke. Clots can form on diseased carotid arteries in the neck. Small parts of these clots can released to form microemboli, which can travel to block key brain arteries and lead to weakness, disturbed speech, loss of vision and other serious stroke syndromes. Standard anti-platelet drugs such as aspirin may not prevent the formation of harmful microemboli.

The scanning process can be used to find patients at very high risk of stroke because microemboli have formed despite prior anti-platelet drugs. Using scanning, the team has found that tirofiban, another anti-platelet drug designed to inhibit the formation of blood clots, can suppress microemboli where previous treatment such as aspirin has been ineffective. In their study, tirofiban was more effective than other ‘rescue’ treatment.

Professor Singer said: “These findings show that the choice of rescue medicine is very important when carotid patients develop microemboli despite previous treatment with powerful anti-platelet drugs such as aspirin. We now need to go on to further studies of anti-microemboli rescue treatments, to aim for the right balance between protection and risk for our patients.”

Professor Imray said: “These findings show the importance of ultrasound testing for micro-emboli in carotid disease patients. These biomarkers of high stroke risk cannot be predicted just from assessing the severity of risk factors such as smoking history, cholesterol and blood pressure.”

Source : http://www.news-medical.net/news/20121122/Tirofiban-effectively-prevents-strokes-in-high-risk-patients.aspx

Full story

Tirofiban effectively prevents strokes in high risk patients

Tirofiban effectively prevents strokes in high risk patients

Scientists may have discovered a new way to prevent strokes in high risk patients, according to research from the University of Warwick and University Hospitals Coventry and Warwickshire (UHCW).

Work by a new research group, led by Professor Donald Singer, Professor of Therapeutics at Warwick Medical School and Professor Chris Imray from UHCW, has now been published in US journal Stroke.

The group is using ultrasound scanning to look at patients with carotid artery disease, one of the major causes of stroke. Clots can form on diseased carotid arteries in the neck. Small parts of these clots can released to form microemboli, which can travel to block key brain arteries and lead to weakness, disturbed speech, loss of vision and other serious stroke syndromes. Standard anti-platelet drugs such as aspirin may not prevent the formation of harmful microemboli.

The scanning process can be used to find patients at very high risk of stroke because microemboli have formed despite prior anti-platelet drugs. Using scanning, the team has found that tirofiban, another anti-platelet drug designed to inhibit the formation of blood clots, can suppress microemboli where previous treatment such as aspirin has been ineffective. In their study, tirofiban was more effective than other ‘rescue’ treatment.

Professor Singer said: “These findings show that the choice of rescue medicine is very important when carotid patients develop microemboli despite previous treatment with powerful anti-platelet drugs such as aspirin. We now need to go on to further studies of anti-microemboli rescue treatments, to aim for the right balance between protection and risk for our patients.”

Professor Imray said: “These findings show the importance of ultrasound testing for micro-emboli in carotid disease patients. These biomarkers of high stroke risk cannot be predicted just from assessing the severity of risk factors such as smoking history, cholesterol and blood pressure.”

Source : http://www.news-medical.net/news/20121122/Tirofiban-effectively-prevents-strokes-in-high-risk-patients.aspx

Full story

VitaScan LT USB Bladder Scanner Receives FDA Approval

VitaScan LT USB Bladder Scanner Receives FDA Approval

VitaScan LT USB Bladder Scanner Receives FDA Approval

MINNEAPOLIS, Nov. 16, 2012 /PRNewswire/ — Vitacon AS, located in Trondheim, Norway, announces major milestones as it continues to expand its global reach. Vitacon has received FDA clearance on its VitaScan LT USB bladder scanner. Vitacon also announces signing a marketing and distribution partnership with SALUS, the Minneapolis-based life science advisory firm.

Non-invasive bladder scanning has become a valuable diagnostic tool. Measuring bladder volume helps avoid indwelling urethral catheters, a major cause of infection. CAUTI (catheter-associated urinary tract infection) treatment is no longer reimbursed if it happens while a patient is hospitalized, thus a major incentive exists to prevent it.

VitaScan LT enables real-time bladder volume measurement in hospitals, clinics, and home health. It connects via USB to laptop and tablets, providing nearly limitless storage and data transmission capabilities. VitaScan software utilizes intelligent targeting algorithms enabling personnel with limited training to obtain accurate measurements in seconds.

SALUS was selected by Vitacon to implement a US marketing and distribution strategy. “The selection of SALUS is essential to our growth,” says Kristin Waro, CEO of Vitacon. “We found their approach unique as they not only created a thorough strategy, but also have the expertise and distribution connections to execute the plan.”

SALUS will be responsible for pre-sales support, logistics, and customer service for a nationwide network of distributors. Spencer Lien, SALUS CEO, says, “Vitacon hit our market perfectly, responding to the need for speed, mobility, and cost-effectiveness. Our research indicates a void in the marketplace and we are confident the respective channels to healthcare providers will be equally impressed.”

About Vitacon:

Vitacon AS was founded in 1985 in Trondheim, Norway. Vitacon develops products to treat incontinence and diagnose bladder dysfunction. Vitacon products are well-known throughout Europe. The company has moved into diagnostic ultrasound and recently launched the VitaScan series of ultrasound scanners offering flexible and cost-effective solutions in bladder volume measurements.

About SALUS:

Salus Consilium, LLC was founded in 2008 by veteran medtech entrepreneur, Spencer Lien. The firm specializes in advising new medical technology ventures and established companies on growth strategies and technology management. Headquartered in Minnesota’s “Medical Alley,” SALUS offers a variety of services including business development, regulatory and reimbursement strategies, commercialization plans, intellectual property management, and technology transfer.

3D USB Ultrasound Probe

- Probe and tablet in softcase for portable solution or connected to mobile cart

- Simple and intuitive software

- Touchscreen or keyboard input

- PC/Laptop/medical grade running Windows XP/Vista/Win 7

- USB 2.0 Type A, Female

- Storage of images, records and reports & also to EMR (Electronic Medical Recording)

Vitacon, from Trondheim, Norway, has received FDA clearance for the VitaScan LT USB bladder scanner. The VitaScan LT consists of a handheld 3D ultrasound probe that connects to a standard Windows-running laptop or tablet using USB. It enables real-time bladder volume measurement in hospitals, clinics and home health.

Bladder volume measurements are almost fully automatic and happen within just a few seconds, only requiring the operator to keep the probe in the right place. Both a three-dimensional image and calculated volumes are displayed. Storage of images, records and reports can be done on the connected computing device or directly in the EMR.

Source : http://www.prnewswire.com/news-releases/vitacon-receives-fda-510k-clearance-and-creates-us-presence-179638671.html

Full story

Appleprobe, An Ultrasound Probe With Sonographer in Mind

Appleprobe, An Ultrasound Probe With Sonographer in Mind

Appleprobe, An Ultrasound Probe With Sonographer in Mind

Italy’s design firm called Rezzonico Design has created an ultrasound probe with a more ergonomic shape, which may take a lot of the pain out of being a sonographer. The Appleprobe, as the product is called, is manufactured by The Esaote Group from Genoa. The device won a Silver from the 2008 International Design Excellence Awards (IDEA) in the Medical & Scientific category.

From IDEA:

The appleprobe is an ultrasound transducer probe that can be held with a traditional pincer grip as well as in a new way that follows the natural alignment of the hand and wrist. Sonographers often experience repetitive strain injuries in their hands and wrists that are believed to be caused by the pinching and pushing of the pincer grip. This dual grip allows sonographers to switch the way they hold the ultrasound transducer throughout the exam and throughout the day, reducing discomfort and injuries.

Source : http://www.idsa.org/IDEA_Awards/gallery/2008/award_details.asp?ID=664

Full story

EUROECHO 2012 reveals how imaging improves early diagnosis of atherosclerosis

EUROECHO 2012 reveals how imaging improves early diagnosis of atherosclerosis

“Atherosclerosis is the leading cause of cardiovascular disease and the leading killer in Europe,” said Professor Patrizio Lancellotti, President-Elect of the EACVI and Chairman of the EUROECHO Scientific Programme Committee. “Many of these deaths could be averted by diagnosis at a preclinical stage or early after the onset of symptoms.”

He added: “Echocardiography and other imaging modalities play an important role in the diagnosis of atherosclerosis. For example, many of the features associated with a high risk plaque can now be probed by novel imaging techniques such as ultrasound imaging of carotid intima-media thickness, contrast enhanced ultrasound, magnetic resonance imaging (MRI) and positron emission tomography (PET).”

Professor Luigi Badano, EACVI President, continued: “We now have the tools to image the early signs of atherosclerosis without waiting for symptoms or clinical manifestations.”

This breakthrough is the focus of the first theme of the congress, imaging atherosclerosis.

EUROECHO 2012 is one of the largest echo and imaging meetings in the world and is expected to attract more than 3,000 cardiologists, internists, cardiac surgeons and sonographers from over 90 countries. This year promises four days of the latest science and treatment monitoring options in cardiovascular imaging, with an abundance of news stories for journalists. The full scientific programme is available here.

Nearly 700 original scientific abstracts will be presented by international scientists on hot topics such as increasing the viability of hearts for transplantation, cardiovascular risks in patients with HIV, the links between obstructive sleep apnea and heart disease, and assessing the cardiac damage induced by cancer drugs.

“The aim is to create an exciting forum for both clinicians and scientists to present and discuss the most up-to-date research and clinical findings in echocardiography and cardiovascular imaging,” said Professor Lancellotti. “The most exciting part of the meeting will be dedicated to how new technology on echocardiography (contrast echo, tissue Doppler imaging, 3D echo, stress echocardiography) and other modalities can enter the clinical arena in the interest of the patient.”

The second theme of the congress is non-invasive cardiovascular imaging techniques and outcome. Professor Lancellotti said: “A rapid echo-guided puncture of a pericardial effusion can save the life of a patient with cardiac tamponade.”

He added: “Most often, imaging outcome is derived from risk stratification and detection of any cardiac involvement at an earlier stage. Early detection is of importance because early intervention may slow down the progression of the disease or appropriate follow-up monitoring can be started.”

New echocardiographic techniques such as tissue Doppler imaging and 2D speckle tracking of myocardial dysfunction enable detection of subtle abnormalities in left ventricular function before any changes in ejection fraction (used to define a normal function). Imaging can also be used to detect cardiotoxicity of cancer drugs. Professor Lancellotti said: “We cannot necessarily prevent the cardiotoxicity but we can detect the cardiac effect earlier and then adapt the treatment.”

Special sessions have been organised for delegates under the age of 35 by the EACVI Club 353 committee. EACVI membership in this age group has increased from 5% to 25% over the past year. For the first time this year there will be two young investigator awards, one for clinical research and one for basic research.

Professor Badano concluded: “Today it is not just echocardiography that can improve patient outcome, but also magnetic resonance imaging, computed tomography and nuclear cardiology. Cardiovascular imaging can be used to improve diagnosis, guide interventional procedures and assess the results of cardiac surgery.”

Source : http://www.news-medical.net/news/20121108/EUROECHO-2012-reveals-how-imaging-improves-early-diagnosis-of-atherosclerosis.aspx

Related Posts Plugin for WordPress, Blogger...

Full story

Page 1 of 3123
Copyright © 2017 Medical Technology & Gadgets Blog MedicalBuy.net. All rights reserved.
Proudly powered by WordPress. Developed by Deluxe Themes